Key facts
- Synaptive Medical’s last known valuation is $314.0M (Jun 2017).
- It has raised $260.1M across 9 recorded rounds; the latest was Seed Round ($5.0M) in Mar 2019.
- Synaptive Medical has filed 10 Form Ds with the SEC since 2014, most recently Apr 2019 ($5.0M sold to 1 investors).
- Status: Privately Held (backing).
- ·Post-money valuations for all 9 rounds
- ·Watchlist + deal alerts for Synaptive Medical
Funding rounds
9 roundsAbout Synaptive Medical
Developer of a global medical technology company designed to solve surgical, imaging and data challenges to improve the quality of human lives. The company's products offer interdisciplinary collaboration to support healthcare professionals, through the synergy of quality information and cutting-edge automation at all stages of clinical intervention and include advanced tools and information for neurosurgeons, radiologists, surgeons and hospitals to focus on patient outcomes, as well as help in surgical planning, navigation and visualization, enabling healthcare professionals to ensure the fast recovery of the patients.
- Sector
- Healthcare
- HQ
- Mississauga, Canada
- Founded
- 2012
- Employees
- 129
- Website
- synaptivemedical.com/
- Ownership
- Privately Held (backing)
Synaptive Medical doesn't have a composite mark yet — a PA Mark is published once enough pricing inputs exist (trade prints, fund marks, round prices). The rest of the record below builds toward it.
Recorded secondary trades
No secondary trades in Synaptive Medical shares have been recorded yet. When a print lands — third-party, direct report, or platform — it appears here with structure, source, and price.
Institutional fund marks
No SEC-registered fund has reported a fair-value mark on Synaptive Medical in its N-PORT filings yet. We sweep new filings monthly.